Home > Insider Trading > Filing (0000904454-15-000528)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070336	Achillion Pharmaceuticals Inc	ACHN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1196863	Nicole Vitullo	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-08-14	37,843	$7.51	21,318	No	4	S	Indirect	By DP VIII Associates, L.P.
Common Stock	Disposition	2015-08-18	483,521	$0.00	0	No	4	J	Indirect	By One Palmer Square Associates VIII, LLC
Common Stock	Acquisiton	2015-08-18	31,431	$0.00	31,431	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By DP VIII Associates, L.P.
No	4	J	Indirect	By One Palmer Square Associates VIII, LLC
No	4	J	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,000	Indirect	By Domain Associates, LLC

Footnotes

Distribution of shares in kind by One Palmer Square Associates VIII, LLC pro rata to its members.
The Reporting Person is a Managing Member of Domain Associates, LLC and a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.58. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.